- $5.69bn
- $4.63bn
- $1.23bn
Annual income statement for Klaviyo, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 291 | 473 | 698 | 937 | 1,234 |
| Cost of Revenue | |||||
| Gross Profit | 206 | 345 | 521 | 716 | 921 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 370 | 528 | 1,029 | 1,022 | 1,302 |
| Operating Profit | -79.2 | -55 | -331 | -84.1 | -67.8 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -79.1 | -49.1 | -307 | -43.7 | -30.5 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -79.4 | -49.2 | -308 | -46.1 | -31.8 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -79.4 | -49.2 | -308 | -46.1 | -31.8 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -79.4 | -49.2 | -308 | -46.1 | -31.8 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.315 | -0.195 | -1.17 | -0.173 | -0.1 |
| Dividends per Share |